A randomized phase II study of autologous cytokine-induced killer cells in treatment of hepatocellular carcinoma.
about
Immunobiology of hepatocarcinogenesis: Ways to go or almost there?Effect and Molecular Mechanisms of Traditional Chinese Medicine on Regulating Tumor Immunosuppressive MicroenvironmentHarms and benefits of adoptive immunotherapy for postoperative hepatocellular carcinoma: an updated reviewAutologous transplantation of cytokine-induced killer cells as an adjuvant therapy for hepatocellular carcinoma in Asia: an update meta-analysis and systematic reviewCytokine-induced killer (CIK) cells in cancer immunotherapy: report of the international registry on CIK cells (IRCC).Cellular immunotherapy as maintenance therapy prolongs the survival of the patients with small cell lung cancer.NMFBFS: A NMF-Based Feature Selection Method in Identifying Pivotal Clinical Symptoms of Hepatocellular Carcinoma.Timely meta-analysis on the efficacy of adoptive immunotherapy for hepatocellular carcinoma patients after curative therapy.Dual Effects of Cellular Immunotherapy in Inhibition of Virus Replication and Prolongation of Survival in HCV-Positive Hepatocellular Carcinoma Patients.Efficacy of RetroNectin-activated cytokine-induced killer cell therapy in the treatment of advanced hepatocelluar carcinoma.HLA-E inhibitor enhances the killing of neuroblastoma stem cells by co-cultured dendritic cells and cytokine-induced killer cells loaded with membrane-based microparticlesEfficacy of cytokine-induced killer cell infusion as an adjuvant immunotherapy for hepatocellular carcinoma: a systematic review and meta-analysis.Comparative investigation of the effects of specific antigen‑sensitized DC‑CIK and DC‑CTL cells against B16 melanoma tumor cells.Cytokine-induced killer cells as immunotherapy for solid tumors: current evidence and perspectives.Immunological landscape and immunotherapy of hepatocellular carcinoma.Cancer Immunotherapy with Cytokine-Induced Killer Cells.Specific immunotherapy in hepatocellular cancer: A systematic review.Promising new strategies for hepatocellular carcinoma.Immune-Mediated Therapies for Liver Cancer.Cell-based immunotherapy with cytokine-induced killer (CIK) cells: From preparation and testing to clinical application.Efficacy of Tumor-Infiltrating Lymphocytes Combined with IFN-α in Chinese Resected Stage III Malignant Melanoma.Lentiviral delivery of CTLA-4 shRNA improves the expansion of cytokine-induced killer cells and enhances cytotoxic activity in vitro.Novel TLR7 agonist stimulates activity of CIK/NK immunological effector cells to enhance antitumor cytotoxicity.Current frontline approaches in the management of hepatocellular carcinoma: the evolving role of immunotherapy
P2860
Q26738293-B269548E-196D-4475-9A8D-AB8AE1D637A6Q26864045-DD7F1F7A-5778-4902-A9AE-89B7EC5B3E98Q33567018-676CFDB0-2F8A-40E9-9663-22A7D5999F6DQ33761739-E5B6C8C8-B8D2-484F-BFD2-C9A427255E70Q34446934-8F637039-1EC0-44E3-A2FE-C1319A0FA47EQ35655447-2489EA91-6821-48ED-819F-1ED58CEE788CQ36249939-C2905280-E25B-4D9C-AC77-AC00653846B3Q36322143-A96ADC21-3834-4A84-BDA4-BCACDD81C2ACQ36741778-59238AAE-7C10-4C28-8606-BB370887F3D9Q37002698-8EDA7B15-78A4-49C6-9D3B-E65036FA2640Q37680008-8ED7F5E6-7A00-4A3B-8C0C-CED111C40FADQ37718809-27A7FD18-23EB-4896-9372-611DF57FEE47Q37720231-38B3BA03-213B-4C43-B865-6932B5C12CDDQ38574526-231974CE-1A68-4308-AD51-097712D1CCB8Q38611895-B64F6656-1D14-4DDC-821E-5B48F5CFA8ABQ38687547-11D66671-1E46-4518-AF25-6550F5951200Q38840178-75C57343-239B-493B-8988-2497618AD0A0Q38936589-E9E5A9F7-F07F-4C39-B8BC-552CAE8AAB1AQ39144327-B73C4730-78AB-4803-9EA9-C9D59FD10C92Q40289330-FF4AC42C-2788-4FEF-92A4-7295A3268655Q41622513-22AFB02F-08FF-432B-A9AB-B01E393AC70DQ49335229-F4334E1A-397E-4976-B068-DA3599788F18Q52649735-F29CC3DF-AAA7-45A5-ABDE-D6626EC74D09Q58117622-02EFEEBE-B2AF-4D49-AEC8-9355FA30EB91
P2860
A randomized phase II study of autologous cytokine-induced killer cells in treatment of hepatocellular carcinoma.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
A randomized phase II study of ...... t of hepatocellular carcinoma.
@en
type
label
A randomized phase II study of ...... t of hepatocellular carcinoma.
@en
prefLabel
A randomized phase II study of ...... t of hepatocellular carcinoma.
@en
P2093
P2860
P1476
A randomized phase II study of ...... t of hepatocellular carcinoma.
@en
P2093
Baozhu Ren
Naining Zhang
Xiaozhou Yu
Xiubao Ren
P2860
P2888
P304
P356
10.1007/S10875-013-9976-0
P577
2013-12-15T00:00:00Z
P6179
1023252524